1 Thygesen K, "Third universal definition of myocardial infarction" 9 : 620-633, 2012
2 Thygesen K, "Third universal definition of myocardial infarction" 7 : 275-295, 2012
3 Löfmark R, "The temperature course in acute myocardial infarction" 96 : 153-156, 1978
4 Celik T, "The impact of admission C-reactive protein levels on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction" 16 : 293-299, 2005
5 van Werkum JW, "Staphylococcus aureus infection complicating percutaneous coronary interventions" 128 : 201-206, 2008
6 Cerqueira MD, "Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association" 105 : 539-542, 2002
7 Tavakol M, "Risks and complications of coronary angiography : a comprehensive review" 4 : 65-93, 2012
8 Banai S, "Prospective study of bacteremia after cardiac catheterization" 92 : 1004-1007, 2003
9 Tomoda H, "Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction" 140 : 324-328, 2000
10 Goel MS, "Neutrophil enhancement of fibrin deposition under flow through platelet-dependent and-independent mechanisms" 21 : 2093-2098, 2001
1 Thygesen K, "Third universal definition of myocardial infarction" 9 : 620-633, 2012
2 Thygesen K, "Third universal definition of myocardial infarction" 7 : 275-295, 2012
3 Löfmark R, "The temperature course in acute myocardial infarction" 96 : 153-156, 1978
4 Celik T, "The impact of admission C-reactive protein levels on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction" 16 : 293-299, 2005
5 van Werkum JW, "Staphylococcus aureus infection complicating percutaneous coronary interventions" 128 : 201-206, 2008
6 Cerqueira MD, "Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association" 105 : 539-542, 2002
7 Tavakol M, "Risks and complications of coronary angiography : a comprehensive review" 4 : 65-93, 2012
8 Banai S, "Prospective study of bacteremia after cardiac catheterization" 92 : 1004-1007, 2003
9 Tomoda H, "Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction" 140 : 324-328, 2000
10 Goel MS, "Neutrophil enhancement of fibrin deposition under flow through platelet-dependent and-independent mechanisms" 21 : 2093-2098, 2001
11 Geppert A, "Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6" 30 : 1987-1994, 2002
12 Palmerini T, "Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system" 44 : 1570-1577, 2004
13 Lindahl B, "Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease" 343 : 1139-1147, 2000
14 Libby P, "Inflammation and atherosclerosis" 105 : 1135-1143, 2002
15 Alkan M, "Infectious complications of acute myocardial infarction" 7 : 220-222, 1986
16 Naito K, "Increased body temperature after reperfused acute myocardial infarction is associated with adverse left ventricular remodeling" 13 : 25-33, 2007
17 Palmerini T, "Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions : analysis from the harmonizing outcome with revascularization and stent in acute myocardial infarction trial" 123 : 2829-2837, 2011
18 Kuchinskiĭ AP, "Fever in myocardial infarction, its relation with catecholamine excretion and disorders of heart rhythm" 54 : 53-56, 1982
19 Cho HO, "Fever after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction is associated with adverse outcomes" 170 : 376-380, 2014
20 Risøe C, "Fever after acute myocardial infarction in patients treated with intravenous timolol or placebo" 57 : 28-31, 1987
21 Alfonso F, "Fatal infection after rapamycin eluting coronary stent implantation" 91 : e51-, 2005
22 Palmerini T, "Effects of abciximab on the acute pathology of blood vessels after arterial stenting in nonhuman primates" 40 : 360-366, 2002
23 Jeger RV, "Causes of death and re-hospitalization in cardiogenic shock" 9 : 25-33, 2007
24 Hochman JS, "Cardiogenic shock complicating acute myocardial infarction : expanding the paradigm" 107 : 2998-3002, 2003
25 Ben-Dor I, "Body temperature-a marker of infarct size in the era of early reperfusion" 103 : 169-173, 2005
26 Herlitz J, "Body temperature in acute myocardial infarction and its relation to early intervention with metoprolol" 20 : 65-71, 1988
27 Newby LK, "ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations : a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents" 60 : 2427-2463, 2012
28 Grech ED, "ABC of interventional cardiology: percutaneous coronary intervention. II: the procedure" 326 : 1137-1140, 2003
29 Amsterdam EA, "2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes : executive summary : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines" 130 : 2354-2394, 2014